If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the ...
In-silico trials (ISTs) are rapidly emerging as an integral part of pharmaceutical R&D and regulatory evaluation. These computational simulations enable researchers to digitally model drug candidates, ...
The 33rd Vietnam International Medical and Pharmaceutical Exhibition (Vietnam Medi-Pharm 2025) and the International ...
Quantum Materials Market to Hit USD 96.9 Billion by 2032 as the Race for Quantum Computing, Next-Gen Semiconductors, and Topological Electronics Accelerates Globally ...
But, unfortunately there is no exclusive central ministry for pharma and medical devices. The Covid-19 pandemic and more recently the US government’s imposition of 100 per cent tariff on ...
According to Frost & Sullivan's data analysis, China's overall medical device market size grew from 729.8 billion RMB in 2020 to 941.7 billion RMB in 2024, with a CAGR of 6.6%. During the same period ...
Nigeria's efforts to curb recurring cholera outbreaks have received a major boost as the government of Japan, in collaboration with the World Health Organisation (WHO), donated $500,000 worth of ...
Japan and WHO donate $500,000 in supplies to support Nigeria's cholera response, aiming to enhance outbreak management and save lives across the country.
The FMI report, “Medical Coatings Market Size, Share, and Forecast 2025–2035,” indicates global revenues will grow by nearly ...
Japan's Ministry of Economy, Trade and Industry plans to invest JPY100 billion (US$671 million) in Rapidus in fiscal 2025, ...
PRELIMINARY PROSPECTUS ACCESSIBLE ON SEDAR+ NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES ...
Discover key life sciences development projects, biotech and pharma innovations, academic partnerships, workforce strategies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback